Knowledge, Practices, and Barriers to HIV Preexposure Prophylaxis Prescribing Among Washington State Medical Providers

Sexually Transmitted Diseases
Brian R WoodJoanne D Stekler

Abstract

We aimed to assess HIV preexposure prophylaxis (PrEP) awareness and prescribing practices among Washington State medical providers from diverse professional disciplines and practice types. In May 2016, we administered an anonymous online survey to licensed medical practitioners who provide primary, longitudinal, walk-in, emergency, obstetric, gynecologic, sexually transmitted infection, or family planning care. Of 735 eligible providers, 64.8% had heard of PrEP. Younger providers and providers with a doctor of medicine degree were more likely to be aware of PrEP compared with older providers (P = 0.0001) and providers of other training backgrounds (advanced registered nurse practitioner, doctor of osteopathic medicine, or physician assistant; P = 0.04). Among providers aware of PrEP, most frequent reported concerns about prescribing were adherence (46.0%) and costs (42.9%). Providers felt very (20.1%) or somewhat (33.8%) comfortable discussing PrEP overall, but very (26.8%) or somewhat (44.7%) uncomfortable discussing cost and insurance issues. The 124 PrEP prescribers reported a median of 2 (range, 1-175; total, 1142) patients prescribed PrEP. Prior authorizations and insurance denials had prevented prescriptions for 28.7% and...Continue Reading

References

Oct 4, 2012·Current Opinion in HIV and AIDS·Douglas Krakower, Kenneth H Mayer
Dec 10, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Maile Y KarrisPhilip M Polgreen
Aug 14, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Colleen F KelleyEli S Rosenberg
Sep 20, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Douglas S KrakowerKenneth H Mayer
Sep 30, 2015·Current Opinion in HIV and AIDS·Douglas S Krakower, Kenneth H Mayer
Oct 26, 2016·Journal of General Internal Medicine·Oni J BlackstockE Jennifer Edelman
Dec 18, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hsiu WuKaren W Hoover

❮ Previous
Next ❯

Citations

Aug 29, 2019·Journal of the International AIDS Society·Maria N PyraJared M Baeten
Jul 3, 2019·PloS One·Javier Martínez SanzUNKNOWN DRIVE 03, OPTtest WP5 and FOCO Study Groups
Jun 23, 2019·Current Infectious Disease Reports·Victoria E PowellDouglas S Krakower
Jan 17, 2020·American Journal of Public Health·Maria PyraJohn Schneider
Apr 23, 2019·The Journal of the Association of Nurses in AIDS Care : JANAC·Patrick OʼByrneDave Holmes
Feb 20, 2020·AIDS Education and Prevention : Official Publication of the International Society for AIDS Education·Christopher OwensBrian Dodge
Feb 29, 2020·AIDS Patient Care and STDs·Benedikt PleuhsSteven A John
Apr 9, 2019·The Journal of the Association of Nurses in AIDS Care : JANAC·Sarahmona PrzybylaNoelle St Vil
Jun 14, 2019·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Kelly A JohnsonStephanie E Cohen
Dec 12, 2018·Obstetrics and Gynecology·Allison A C EubanksNancy C Chescheir
Oct 4, 2019·Journal of Primary Care & Community Health·Margaret R CarterKathleen A Brady
Sep 11, 2020·Journal of HIV/AIDS & Social Services·Jacob BleasdaleSarahmona Przybyla
Jan 31, 2020·AIDS and Behavior·Jonathan PicardJulie Bruneau
Apr 2, 2020·Advances in Therapy·Kenneth H MayerDavid Malebranche
Nov 14, 2018·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Brett A TortelliRupa R Patel
Feb 1, 2019·Current HIV/AIDS Reports·Rebecca Touger, Brian R Wood
Feb 23, 2020·Journal of General Internal Medicine·Samuel R BuntingTimothy J Keyes
Dec 29, 2020·Journal of Primary Care & Community Health·Emily MooreApril C Pettit
Sep 4, 2020·Human Vaccines & Immunotherapeutics·Tanner M JohnsonKimberly K Scarsi
Oct 16, 2021·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Weiming ZhuKaren W Hoover

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved